Cargando…
Screening of aptamers specific to colorectal cancer cells and stem cells by utilizing On-chip Cell-SELEX
Colorectal cancer (CRC) is the most frequently diagnosed cancer around the world, causing about 700,000 deaths every year. It is clear now that a small fraction of CRC, named colorectal cancer stem cells (CSCs) exhibiting self-renewal and extensive proliferative activities, are hard to be eradicated...
Autores principales: | Hung, Lien-Yu, Wang, Chih-Hung, Che, Yu-Jui, Fu, Chien-Yu, Chang, Hwan-You, Wang, Kuan, Lee, Gwo-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650677/ https://www.ncbi.nlm.nih.gov/pubmed/25999049 http://dx.doi.org/10.1038/srep10326 |
Ejemplares similares
-
Generating Cell Targeting Aptamers for Nanotheranostics Using Cell-SELEX
por: Lyu, Yifan, et al.
Publicado: (2016) -
A modified SELEX approach to identify DNA aptamers with binding specificity to the major histocompatibility complex presenting ovalbumin model antigen
por: Lin, Yang, et al.
Publicado: (2023) -
CELL-SELEX: Novel Perspectives of Aptamer-Based Therapeutics
por: Guo, Ke-Tai, et al.
Publicado: (2008) -
Generating Aptamers by Cell-SELEX for Applications in Molecular Medicine
por: Ye, Mao, et al.
Publicado: (2012) -
DNA Aptamer Evolved by Cell-SELEX for Recognition of Prostate Cancer
por: Wang, Yuanyuan, et al.
Publicado: (2014)